Skip to content
Open access

LUCas: Light-Uncaged Cas13a using photocleavable interfering guide RNAs

Aug 2026 · Nucleic Acids Research · Vol 54 · 0 citations · 44 references
Medicine

Abstract

Abstract CRISPR diagnostics enable sensitive detection of infectious diseases, with the RNA endonuclease Cas13a providing specific, amplification-free RNA detection through collateral trans-cleavage of fluorescent reporters. However, background cleavage from unbound enzyme, contaminating nucleases, and unsynchronized initiation of reactions limits assay sensitivity and interpretability. A strategy to precisely control the onset of Cas13a catalytic activity, essentially a molecular “starting gun,” would address these challenges. Here, we introduce Light-Uncaged Cas13a (LUCas), a light-controllable system that directly blocks Cas13a trans-cleavage activity using a photocleavable interfering guide RNA, even in the presence of target RNA. Brief UV illumination releases this suppression, restoring full activity. Quantitative kinetic analysis reveals an ~100-fold suppression of trans-cleavage activity prior to photo-uncaging, including suppression of target-independent background activity. Using measured kinetic parameters, we predict and experimentally validate the limit of detection of the LUCas system for direct detection. We further demonstrate a multiplexed detection strategy termed “temporal barcoding,” enabling quantitative detection of viral co-infections in a single bulk reaction. Finally, LUCas is shown to be compatible with one-pot isothermal amplification for enhanced sensitivity and direct detection of target RNA spiked into blood plasma. Together, these results establish LUCas as a general framework for mechanistically informed, light-based control of Cas13a activity.

Read PDF

Similar papers

Sep 2026

Photoactivatable NPOM-caged split-activator CRISPR/Cas12a biosensor for amplification-free imaging of deoxynivalenol-induced miR-155 dynamics and lateral-flow sensing.

MicroRNA-155 (miR-155) is an immune-associated small RNA biomarker involved in macrophage responses to environmental stressors such as deoxynivalenol (DON). However, achieving amplification-free miRNA sensing with low background and precise temporal regulation remains challenging. Here, we develop a photoactivatable sp...

Kuan-Wen Chang, Jia-Di Sun, Tao Liu et al. · 0 citations
Sep 2026

Split Activator Assembly via Aptamer Binding Enables CRISPR-Cas12a Activation With Non-Nucleic Acid Targets.

The programmability of CRISPR-Cas12a has enabled transformative advances in nucleic acid detection; however, extending its activation to non-nucleic-acid targets remains highly desirable. Here, we report a universal split-activator strategy that enables programmable Cas12a activation in response to a small molecule and...

R. J. Tharu, Y. Imtiaz, Shubhajit Singha et al. · 0 citations
Aug 2026

Phosphorothioate-Enabled Cas12a Autocatalytic Network for Amplification-Free Ultrasensitive Nucleic Acid Detection.

Autocatalytic CRISPR/Cas systems offer a promising route toward amplification-free nucleic acid detection, yet their performance is limited by indiscriminate transcleavage of ssDNA activators and the reliance on structurally complex, thermodynamically unstable DNA architectures. A phosphorothioate (PS)-enabled Cas12a a...

Run-Ze Zhang, Zaiwei Wen, Yong Zhao et al. · 0 citations
Open access Aug 2026

Invasive RNA Programs Optical Switching in DNA Nanoclusters for CRISPR Sensing

DNA-templated silver nanoclusters have regained attention due to recent advances in stability and tunable optical properties. Here, we report a highly regulated DNA-templated silver nanocluster (DFN2) that exhibits strong fluorescence at 561 nm and enables reversible, label-free fluorescence switching governed by nucle...

Reggie Gold, Y. Imtiaz, Vinod Morya et al. · 1 citation
Aug 2026

An Amplified Luminescent Proximity Homogeneous Assay-Implemented CRISPR/Cas13a System for Noncoding RNA Detection

The Alpha-CRISPR RNA detection system developed in this study integrates AlphaLISA technology with the CRISPR-Cas13a system, achieving significantly enhanced detection sensitivity, demonstrating substantial application potential in fundamental medical research and clinical diagnostics.

Yaofan Lu, Zhen-Ya Cheng, Zheng Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.